Steroid therapy for late nerve damage after throat cancer radiation
Treatments studied
Part of Brain & nervous system, Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests whether high-dose steroids (prednisone or methylprednisolone) can improve symptoms of nerve damage that may occur years after radiation treatment for oropharyngeal cancer. It includes a registry for tracking similar nerve issues in head and neck cancer survivors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years past radiation treatment for throat cancer and currently cancer-free.
- You have nerve damage affecting your tongue or swallowing muscles (cranial nerves XII or X) that is likely caused by radiation, not by a new tumor.
- You can complete a symptom survey in one of these languages: English, simplified Chinese, Filipino, Greek, Japanese, Korean, Russian, Spanish, or Taiwanese.
- Your diabetes, blood pressure, and other health conditions are under control (no uncontrolled diabetes or high blood pressure).
- You are not pregnant, have no active stomach ulcer, history of psychosis or bipolar disorder, or a stricture in your throat that cannot be treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called Ajovy (fremanezumab) to see if it can help prevent or treat early nerve damage in the tongue or throat area that can happen after treatment for throat cancer. It may help improve swallowing, speech, and quality of life.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial compares two different treatments after surgery for advanced head and neck cancer (oral or oropharyngeal). It tests whether radiation therapy or continuing an immunotherapy drug (called PD-1 inhibitor) leads to better survival. This study might help you decide which follow-up treatment could be better for your situation.
This trial tests if adding a steroid (methylprednisolone) to standard chemotherapy and radiation helps people with thymoma that cannot be fully removed by surgery or has come back. The goal is to see if this combination works better at controlling the disease.
This study tests an approach called “adaptive radiotherapy,” where the radiation plan may be adjusted based on how your tumor and anatomy look during treatment. It is for adults with biopsy-proven oropharyngeal (throat) squamous cell carcinoma who are planning curative radiation, with or without chemotherapy.
This trial tests whether giving steroids after surgery to remove a benign brain tumor (vestibular schwannoma, also called acoustic neuroma) helps protect the facial nerve, which controls facial expressions. It may reduce the chance of facial weakness after surgery.
Hear when a new Cranial Nerve Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.